'Infusion Pump Correction: Baxter Issues Correction for Novum IQ Large Volume Pump due to Potential for Underinfusion' - FDA
Baxter International Inc. -1.48%
Baxter International Inc. BAX | 0.00 |
https://www.fda.gov/medical-devices/medical-device-recalls/infusion-pump-correction-baxter-issues-correction-novum-iq-large-volume-pump-due-potential#:~:text=Medical%20Device%20Recalls-,Infusion%20Pump%20Correction%3A%20Baxter%20Issues%20Correction%20for%20Novum%20IQ%20Large,due%20to%20Potential%20for%20Underinfusion&text=This%20recall%20involves%20correcting%20certain,as%20the%20most%20serious%20type.
Recommend
- Benzinga News 03/11 18:01
How Attractive Is Baxter After a 21% Weekly Drop and Strategic Divestitures in 2025?
Simply Wall St 04/11 06:27InspireMD Q3 EPS $(0.17) Beats $(0.23) Estimate, Sales $2.523M Beat $1.760M Estimate
Benzinga News 04/11 12:01Neuronetics Lowers FY2025 Sales Guidance from $149.000M-$155.000M to $147.000M-$150.000M vs $151.030M Est
Benzinga News 04/11 12:09Barclays Maintains Overweight on Bruker, Raises Price Target to $45
Benzinga News 04/11 14:07BTIG Reiterates Buy on Delcath Systems, Maintains $23 Price Target
Benzinga News 04/11 17:10Masimo Raises FY2025 Adj EPS Guidance from $5.45-$5.70 to $5.62-$5.79 vs $5.33 Est; Narrows FY2025 Sales Guidance from $1.505B-$1.535B to $1.510B-$1.530B vs $1.521B Est
Benzinga News 04/11 21:10Solana Company Announces It Has Applied To Canadian Securities Regulators For An Order To Cease Being A Reporting Issuer In All Canadian Jurisdictions
Benzinga News 04/11 21:21


